metabolic syndrome: where are we and where do we go?

The Metabolic Syndrome, also known as Syndrome X, refers to a constellation of atherosclerotic risk factors, including insulin resistance, hyperinsulinemia, dyslipidemia, essential hypertension, and abdominal obesity. We review four major published studies involving animals and humans that may be li...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition reviews 2002-10, Vol.60 (10), p.335-337
Main Authors: Roth, J.L, Mobarhan, S
Format: Article
Language:English
Subjects:
abdominal fat
abdominal obesity
Animals
atherosclerosis
atherosclerotic risk factors
Biological and medical sciences
body fat
Diet - adverse effects
Diet, Fat-Restricted
Disease
dyslipidemia
essential
Exercise - physiology
Female
human health
Humans
hyperinsulinemia
hypertension
Impact analysis
insulin
insulin resistance
Male
Medical sciences
metabolic syndrome
Metabolic Syndrome - diet therapy
Metabolic Syndrome - physiopathology
Metabolic Syndrome - therapy
Metabolism
Miscellaneous
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Rats
resistance
risk factors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Metabolic Syndrome, also known as Syndrome X, refers to a constellation of atherosclerotic risk factors, including insulin resistance, hyperinsulinemia, dyslipidemia, essential hypertension, and abdominal obesity. We review four major published studies involving animals and humans that may be linked together in a unified hypothesis and justify a comprehensive approach in the treatment of this ever‐increasing syndrome.
ISSN:0029-6643
1753-4887
DOI:10.1301/002966402320583398